The Inhalation Revolution: Strategic B2B Outlook on the Global Aerosol Therapy Market (2026–2033)
In the strategic landscape of 2026, aerosol therapy has moved beyond the “rescue” inhaler to become a sophisticated pillar of pulmonary drug delivery. Driven by a global rise in chronic obstructive pulmonary disease (COPD), asthma, and the long-term respiratory sequelae … Read more